Create Health
1 – 10 of 1016
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2025
-
Mark
In vitro characterisation of a novel rubber contact allergen in protective gloves
(
- Contribution to journal › Article
-
Mark
The Progression of Mycosis Fungoides During Treatment with Mogamulizumab: A BIO-MUSE Case Study of the Tumor and Immune Response in Peripheral Blood and Tissue
(
- Contribution to journal › Article
-
Mark
First-in-human, multicenter, open-label, phase I study of ATOR-1017 (evunzekibart), a 4-1BB antibody, in patients with advanced solid malignancies
(
- Contribution to journal › Article
- 2024
-
Mark
WOMBAT-P : Benchmarking Label-Free Proteomics Data Analysis Workflows
(
- Contribution to journal › Article
-
Mark
LRPPRC and SLIRP synergize to maintain sufficient and orderly mammalian mitochondrial translation
(
- Contribution to journal › Article
-
Mark
In vivo dendritic cell reprogramming for cancer immunotherapy
(
- Contribution to journal › Article
-
Mark
Towards Precision Oncology : Advancing Multiomic Biomarker Discovery with Mass Spectrometry Proteomics
2024)(
- Thesis › Doctoral thesis (compilation)
-
Mark
The quantification of zebrafish ocular-associated proteins provides hints for sex-biased visual impairments and perception
(
- Contribution to journal › Article
-
Mark
Protective Non-neutralizing anti-N-terminal Domain mAb Maintains Fc-mediated Function against SARS-COV-2 Variants up to BA.2.86-JN.1 with Superfluous In Vivo Protection against JN.1 Due to Attenuated Virulence
(
- Contribution to journal › Article
-
Mark
Distinct Infiltration of T Cell Populations in Bladder Cancer Molecular Subtypes
(
- Contribution to journal › Article